Virtual supermarket could help spot thinking problems in alcohol disorder

NCT ID NCT07593664

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to validate a virtual reality version of the Multiple Errands Test for assessing executive functions in people with alcohol use disorder. Ninety participants will complete both a real-world and a virtual supermarket task, along with other cognitive tests. The goal is to see if the virtual version can reliably detect thinking deficits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality-based test
What this could lead to
If successful, this could provide a simpler, more accessible way to measure thinking and planning skills in people with alcohol use disorder.
What could go wrong
This is an early-stage validation study with only 90 participants. The virtual test may not accurately reflect real-world performance or detect all thinking problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * written consent * Normal or corrected vision and hearing * Membership or entitlement to a social security plan * spoken and written French * third party liability insurance for patients only : * at least 6 criteria for AUD based on the Diagnostic and statistical manual of mental disorders * At the end of withdrawal: treatment with a diazepam equivalent of ≤ 20 mg/day Exclusion Criteria: * under tutorship/ judicial protection * Sensory or motor impairment (impeding the use of virtual reality and/or mobility) * Severe neurological disorder (such as dementia or Korsakoff's syndrome) * Photosensitive epilepsy (contraindication for the use of virtual reality) * Any other condition deemed incompatible with the study, at the investigator's discretion * Montreal Cognitive Assessment (MoCA) score \< 10 (severe cognitive impairment) * Breastfeeding or pregnant women * Familiarity with the supermarket visited during the MET test For controls only : * History of alcohol use disorder * score ≥ 8 on the Alcohol Use Disorders Identification Test * Score on the Frontal Assessment Battery \< 16 (or \< 15 if education is below secondary level)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol use disorder (AUD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH Le Vinatier

    Bron, 69500, France

  • Hôpital de la Croix Rousse

    Lyon, 69004, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.